The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November.

Daniil Bash
Daniil Bash

DDW is delighted to welcome Dr Daniil Bash, Lead Scientist at the Innovation Centre in Digital Molecular Technologies (iDMT), University of Cambridge, to the expert speaker line-up.

Bash will be presenting AI-optimisation of flow-based small molecule organic synthesis.

Bash is a materials chemist focused on AI-assisted high-throughput experimentation and the digitisation of synthesis. He earned his PhD at NUS and now works at Cambridge’s iDMT, where he builds AI-driven, robotic, data-rich workflows with inline analytics to accelerate discovery and scale-up of functional materials. Bash has co-founded two deep-tech startups and has a track record of building labs, teams, and workflows from scratch. He combines broad interdisciplinary expertise with practical execution, bridging science, engineering, and entrepreneurship from 0-to-1 to industrial scale.

Bash will be joined by participants from Cancer Research Horizons-AstraZeneca Functional Genomics Centre, Oxford University, Apollo Therapeutics, Gain Therapeutics, The Milner Therapeutics Institute, Alzheimer’s Research UK Oxford Drug Discovery Institute and Shift Bioscience.

This free half day event will feature:

  • 6 in-depth presentations from industry experts
  • a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery process
  • an opportunity for networking

Sponsors:

  • Nuclera (lead sponsor)
  • Collaborative Drug Discovery (coffee break sponsor)
  • Thermo Fisher Scientific

Registration is now open and is subject to availability and eligibility.

Register here.